clinical 2,098 words KG: Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies (NCT07177352)
Contents

Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies (NCT07177352)

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (29)

Multi-Modal CRISPR Platform for Simultaneous Editing and Mon
Score: 0.63
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.90
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.87
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.78
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.74
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.68
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67
Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli
Score: 0.67
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
LRP1-Dependent Tau Uptake Disruption
Score: 0.60
VCP-Mediated Autophagy Enhancement
Score: 0.59
Extracellular Vesicle Biogenesis Modulation
Score: 0.58
Synaptic Vesicle Tau Capture Inhibition
Score: 0.58
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.57
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.54
pg 1/2Next →

Related Analyses (15)

Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Related Experiments (30)

Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40

See Also (15)

ASL Perfusion Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Astrocyte-Derived Exosomal mRNA Reference Genes for Alz
biomarker · Pages share 18 hypotheses
AT(N) Biomarker Classification for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
A/T/N+ Comprehensive Biomarker Panel for Alzheimer's Di
biomarker · Pages share 18 hypotheses
Blood p-Tau217 as a Clock for Alzheimer's Disease Onset
mechanism · Pages share 18 hypotheses

Knowledge Graph (1 edges)

Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies (NCT07177352) references APOE

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.